Dr. Lin Yang

Active surveillance has been recommended as the preferred management strategy to avoid or postpone immediate therapy for low-risk (potentially intermediate-risk) prostate cancer, which accounts for 40-50% of new cases. However, over 40% of men withdrew from active surveillance within five years, primarily due to cancer progression and/or anxiety. Findings from preclinical and clinical studies suggested that exercise may slow prostate tumor growth and reduce anxiety in cancer survivors. We conduct surveys to understand the needs and preference of exercise as a model of low-cost intervention to inform the design of an efficacy trial to delay the transition of men from active surveillance to radical therapy while improving their quality of life.

Funder: University of Calgary